Cargando…

The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients

BACKGROUND: To explore the expression level of has_circ_0000615 in peripheral blood samples and evaluate its diagnostic value for breast cancer patients. METHODS: The peripheral blood samples of 95 breast cancer patients who underwent curative surgical resection and 95 age-matched healthy volunteers...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiani, Peng, Xinyu, Liu, Yinfeng, Hao, Ran, Zhao, Rumeng, Zhang, Lei, Zhao, Fuqing, Liu, Qi, Liu, Yunjiang, Qi, Yixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379395/
https://www.ncbi.nlm.nih.gov/pubmed/34429639
http://dx.doi.org/10.2147/IJGM.S319801
_version_ 1783740996920541184
author Liu, Jiani
Peng, Xinyu
Liu, Yinfeng
Hao, Ran
Zhao, Rumeng
Zhang, Lei
Zhao, Fuqing
Liu, Qi
Liu, Yunjiang
Qi, Yixin
author_facet Liu, Jiani
Peng, Xinyu
Liu, Yinfeng
Hao, Ran
Zhao, Rumeng
Zhang, Lei
Zhao, Fuqing
Liu, Qi
Liu, Yunjiang
Qi, Yixin
author_sort Liu, Jiani
collection PubMed
description BACKGROUND: To explore the expression level of has_circ_0000615 in peripheral blood samples and evaluate its diagnostic value for breast cancer patients. METHODS: The peripheral blood samples of 95 breast cancer patients who underwent curative surgical resection and 95 age-matched healthy volunteers in our institutions from September 2019 to November 2020 were systematically collected. The expression level of has_circ_0000615 in the plasma was amplified and detected by qRT-PCR, and its correlation to clinicopathological characteristics of breast cancer patients were analyzed. RESULTS: Breast cancer patients had a significantly higher expression level of has_circ_0000615 in the plasma than healthy controls (P < 0.01), and its high expression was closely associated with advanced tumor stage (P=0.010), lymph node metastasis (P = 0.001) and high grade of recurrence risk (P=0.012). The receiver operator characteristic (ROC) curves showed that the area under curve (AUC) value, sensitivity and specificity of has_circ_0000615 for the diagnosis of non-metastatic breast cancer was 0.904 (95% CI: 0.863–0.944), 76.8% and 88.4%, respectively. Serum has_circ_0000615 expression had a better diagnostic efficiency than routine tumor biomarkers such as CA153, CA125 and CEA for distinguishing breast cancer patients from healthy individuals. TEM revealed that isolated exosomes from the culture medium of breast cancer cells had a disk-like appearance with a diameter of 80–200 nm vesicles, and the expression of exosome markers CD9 and CD81 was markedly increased. More importantly, the expression of has_circ_0000615 was detected in the exosomes and its expression level was markedly upregulated in breast cancer cell lines compared with normal ductal epithelial cells. The stability assay showed that there was no difference between RNA extraction at 0 hour and 24 hours in terms of the expression of has_circ_0000615 (P =0.327). Has_circ_0000615 might as exosomes be secreted into the circulating blood of breast cancer patients, resulting in a high expression level in plasma samples. CONCLUSION: The detection of has_circ_0000615 might be a promising diagnostic method for breast cancer.
format Online
Article
Text
id pubmed-8379395
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-83793952021-08-23 The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients Liu, Jiani Peng, Xinyu Liu, Yinfeng Hao, Ran Zhao, Rumeng Zhang, Lei Zhao, Fuqing Liu, Qi Liu, Yunjiang Qi, Yixin Int J Gen Med Original Research BACKGROUND: To explore the expression level of has_circ_0000615 in peripheral blood samples and evaluate its diagnostic value for breast cancer patients. METHODS: The peripheral blood samples of 95 breast cancer patients who underwent curative surgical resection and 95 age-matched healthy volunteers in our institutions from September 2019 to November 2020 were systematically collected. The expression level of has_circ_0000615 in the plasma was amplified and detected by qRT-PCR, and its correlation to clinicopathological characteristics of breast cancer patients were analyzed. RESULTS: Breast cancer patients had a significantly higher expression level of has_circ_0000615 in the plasma than healthy controls (P < 0.01), and its high expression was closely associated with advanced tumor stage (P=0.010), lymph node metastasis (P = 0.001) and high grade of recurrence risk (P=0.012). The receiver operator characteristic (ROC) curves showed that the area under curve (AUC) value, sensitivity and specificity of has_circ_0000615 for the diagnosis of non-metastatic breast cancer was 0.904 (95% CI: 0.863–0.944), 76.8% and 88.4%, respectively. Serum has_circ_0000615 expression had a better diagnostic efficiency than routine tumor biomarkers such as CA153, CA125 and CEA for distinguishing breast cancer patients from healthy individuals. TEM revealed that isolated exosomes from the culture medium of breast cancer cells had a disk-like appearance with a diameter of 80–200 nm vesicles, and the expression of exosome markers CD9 and CD81 was markedly increased. More importantly, the expression of has_circ_0000615 was detected in the exosomes and its expression level was markedly upregulated in breast cancer cell lines compared with normal ductal epithelial cells. The stability assay showed that there was no difference between RNA extraction at 0 hour and 24 hours in terms of the expression of has_circ_0000615 (P =0.327). Has_circ_0000615 might as exosomes be secreted into the circulating blood of breast cancer patients, resulting in a high expression level in plasma samples. CONCLUSION: The detection of has_circ_0000615 might be a promising diagnostic method for breast cancer. Dove 2021-08-16 /pmc/articles/PMC8379395/ /pubmed/34429639 http://dx.doi.org/10.2147/IJGM.S319801 Text en © 2021 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Jiani
Peng, Xinyu
Liu, Yinfeng
Hao, Ran
Zhao, Rumeng
Zhang, Lei
Zhao, Fuqing
Liu, Qi
Liu, Yunjiang
Qi, Yixin
The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients
title The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients
title_full The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients
title_fullStr The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients
title_full_unstemmed The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients
title_short The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients
title_sort diagnostic value of serum exosomal has_circ_0000615 for breast cancer patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379395/
https://www.ncbi.nlm.nih.gov/pubmed/34429639
http://dx.doi.org/10.2147/IJGM.S319801
work_keys_str_mv AT liujiani thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT pengxinyu thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT liuyinfeng thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT haoran thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT zhaorumeng thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT zhanglei thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT zhaofuqing thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT liuqi thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT liuyunjiang thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT qiyixin thediagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT liujiani diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT pengxinyu diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT liuyinfeng diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT haoran diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT zhaorumeng diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT zhanglei diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT zhaofuqing diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT liuqi diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT liuyunjiang diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients
AT qiyixin diagnosticvalueofserumexosomalhascirc0000615forbreastcancerpatients